Securities Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AbbVie and Twitter and Encourages Investors to Contact the Firm Pharmaceutical Investing
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline - AUPH Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against AbbVie, Inc. with Lead Plaintiff Deadline Approaching Pharmaceutical Investing
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages AbbVie Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
ABBV Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of AbbVie, Inc. of Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
AURINIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Aurinia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Pharmaceutical Investing
Pomerantz Law Firm Announces the Filing of a Class Action Against Aurinia Pharmaceuticals Inc., and Certain Officers - AUPH Pharmaceutical Investing
CLASS ACTION UPDATE for CRNC, AKBA and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CELH, VLTA and ABBV Pharmaceutical Investing
